Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05979493 · ClinicalTrials.gov registry record · Phase 4
QL Block in Laparoscopic Myomectomy
A Phase 4 study of Postoperative Pain and Fibroid Uterus, sponsored by Joseph Findley MD.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05979493 is a Phase 4 study of Postoperative Pain and Fibroid Uterus that is actively recruiting participants, run by Joseph Findley MD. The registered enrollment target is 80 participants, below the 230-participant average among 63 other Postoperative Pain trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05979493, a Phase 4 study of Postoperative Pain and Fibroid Uterus, is actively recruiting participants, sponsored by Joseph Findley MD.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to determine the efficacy of a quadratus lumborum (QL) block in decreasing postoperative pain in patients undergoing myomectomy for uterine fibroids. A QL block is a temporary anesthetic injection in the quadratus lumborum muscle, a muscle in the lower back, that has been previously shown to significantly reduce postoperative pain levels in patients undergoing abdominal and pelvic surgery. Because of its demonstrated effects, the QL block is becoming a standard of anesthesia and surgical care. Since participants will be undergoing a myomectomy procedure, the investigators believe that participants may qualify to participate in this study. The investigators will be comparing patients who receive the QL block (in addition to standard anesthesia and postoperative pain care) with patients who do not receive the QL block (in addition to standard care). The participants will be randomly assigned to one of the two groups and may or may not actually receive the block.
Conditions Studied
Interventions
- DRUG Bupivacain
- DRUG Saline
Study Locations (1)
Ohio
- University Hospitals Ahuja Medical Center - Beachwood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-08-24 |
| Est. Completion | 2026-07-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05979493
The ClinicalTrials.gov registry entry for NCT05979493 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 230-participant average among 63 other Postoperative Pain trials with a reported enrollment target (65% lower). The listed sponsor is Joseph Findley MD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Postoperative Pain appearing as the primary indexed condition, and to 2 interventions - of which Bupivacain is the first listed.
NCT05979493 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05979493 about?
NCT05979493 is a clinical study titled "QL Block in Laparoscopic Myomectomy". This study aims to determine the efficacy of a quadratus lumborum (QL) block in decreasing postoperative pain in patients undergoing myomectomy for uterine fibroids. A QL block is a temporary anesthetic injection in the quadratus lumborum muscle, a muscle in the lower back, that has been previously ...
What is the current status of trial NCT05979493?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2024-08-24. Estimated completion is 2026-07-03.
What conditions does trial NCT05979493 study?
This clinical trial studies the following conditions: Postoperative Pain, Fibroid Uterus.
What interventions are being tested in trial NCT05979493?
The interventions under investigation include: Bupivacain (DRUG), Saline (DRUG).
Who is sponsoring clinical trial NCT05979493?
This trial is sponsored by Joseph Findley MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05979493 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse
RECRUITING · Phase 4
-
Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients
RECRUITING · Phase 4
-
No Opioids vs. Minimal Opioids Following Inguinal Hernia Repair
ACTIVE NOT RECRUITING · Phase 4
-
Single-shot TAP Block vs Continuous TAP Block
COMPLETED · Phase 4
-
Pain Control With Total Knee Replacement
COMPLETED · Phase 4
-
Intrathecal Morphine for Cesarean Delivery
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.